Comparison of the listed sections of the Shenzhen Stock Exchange and the Shanghai Stock Exchange, involving subject qualifications, independence, standardized operation, finance and accounting, use of fund-raising funds, share capital and public offering ratio, shareholder commitments, information disclosure, etc.

On March 24, the State Food and Drug Administration formally approved Puhui Hua® (Platinib Capsules) as a national first-class new drug for marketing applications for transfection-rearrangement (RET) gene fusion-positive patients who have previously received platinum-containing chemotherapy Treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).